Apolipoprotein A-V, triglycerides and risk of coronary artery disease: the prospective Epic-Norfolk Population Study

This publication has 39 references indexed in Scilit:

• Apolipoprotein A-V Deficiency Results in Marked Hypertriglyceridemia Attributable to Decreased Lipolysis of Triglyceride-Rich Lipoproteins and Removal of Their Remnants
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2005
• Apolipoprotein A-V-heparin Interactions
  Published by Elsevier ,2005
• The Novel Apolipoprotein A5 Is Present in Human Serum, Is Associated with VLDL, HDL, and Chylomicrons, and Circulates at Very Low Concentrations Compared with Other Apolipoproteins
  Clinical Chemistry, 2005
• ApoAV Reduces Plasma Triglycerides by Inhibiting Very Low Density Lipoprotein-Triglyceride (VLDL-TG) Production and Stimulating Lipoprotein Lipase-mediated VLDL-TG Hydrolysis
  Journal of Biological Chemistry, 2004
• Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides
  Human Molecular Genetics, 2002
• Adenoviral overexpression of apolipoprotein A-V reduces serum levels of triglycerides and cholesterol in mice
  Biochemical and Biophysical Research Communications, 2002
• Apolipoprotein A-V
  Journal of Biological Chemistry, 2001
• An Apolipoprotein Influencing Triglycerides in Humans and Mice Revealed by Comparative Sequencing
  Science, 2001
• The apoAI-CIII-AIV gene cluster
  Atherosclerosis, 2001
• Triglycerides: risk factor or fellow traveler?
  Current Opinion in Cardiology, 2001